United States Nuclear Medicine Market by Type (Diagnostic Nuclear Medicine, and Therapeutic Nuclear Medicine), by Application (Neurology, Cardiology, Oncology, and Other) | Nuclear Medicine Market Report by Region (North America, Latin America, Europe, Middle East and Africa, Asia Pacific, Southeast Asia, Northern Asia, Southern Asia) | Forecast Period 2021-2026
United States Nuclear Medicine Market Size Growth Share 2021-2026:
United States Nuclear Medicine Market is segmented into By Type and By Application. Based on Type, the market is subdivided into Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine. Based on the Application segment, it is further classified into Neurology, Cardiology, Oncology, and Other.
United States Nuclear Medicine Market growth is expected to boost due to the increasing investments and research & developments in the country. Implementing the new advanced technologies in the field of imaging have to speed up the growth of the United States Nuclear Medicine Market. Developments in the nuclear medicine market are key recognized to elements such as the growing occurrence and prevalence of cardiac and cancer and advantages. Not only in the United States but also increasing in research and developments in the Canada country leads to the growth of the Canada Nuclear Medicine Market.
North America Nuclear Medicine Market Size 2021-2026:
As per our research analysis, the overall size of the North America Nuclear Medicine Market was valued at USD 5.62 Billion in 2021, and it is expected to reach USD 10.27 Billion by the end of 2026, with growth at a CAGR of 10.6% during the forecast period 2021-2026.
The United States Nuclear Medicine Market size is expected to boost during the forecast period along with a constant growth rate throughout the period of 2021-2026.
In the year 2020, the USFDA (United States Food and Drug Administration) has implemented some guidelines to modify operating measures to minimize the chances of COVID-19 infection between the staff, In-patients, and Out-patients or public.
In the United States, Curium and RadioMedix Inc are launched the PET (positron emission tomography) agent in September 2020. This will helps to detect the localization of somatostatin receptor-positive NETs (neuroendocrine tumors) in adults patients. This innovation is expected to boost the segmental growth during the forecast period 2021-2026.
United States Nuclear Medicine Market Segmentation:
As per our research study, the global market for Nuclear Medicine is classified into By Application and By Type. Depending on the application, the market is divided into Neurology, Cardiology, Oncology, and Other. Depending on the Type, the market is subdivided into Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine.
According to the Data Research Reports analysis, the In the Application segment, the Sub segment Oncology is projected to grip the noteworthy Market Share.
To find the usage of radioisotopes in the diagnosis of several cancers, the research analysis is to be conducted endless. The growing product innovations are also surging the growth of the segment.
During the forecast period, the Thyroid segment is projected to record the utmost growth rate in the Application Segment.
United States Nuclear Medicine Market Drivers and Restraints:
As previously mentioned, increasing encumbrance of diseases, increasing the advancements of technology, and rising approvals of nuclear medicine in the diagnostics as well as on therapeutics lead to the growth of the North America nuclear medicine market.
However, raising the cost of procedures and the therapeutic & diagnostic equipment will be lead the restrains to the nuclear medicine market growth
The United States Nuclear Medicine Market is extremely competitive and involves numerous key companies, along with a few smaller organizations. However, with advancements in technology and innovations of products, middle-level to small companies are growing their market existence by announcing new equipment at a reasonable cost.
United States Nuclear Medicine Market Key Players:
Some of the major players involved in the global Nuclear Medicine Market are; Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., and Advanced Accelerator Applications S.A.
Our Research Insights not restricted: Not only country reports, but we also cover all regions and global market reports. Our research is not restricted to a particular path, we cover all over the world.
Our Research Methodology: Our methodology relies on both primary and secondary research by conducting top-down and bottom-up approaches,
What do we Cover?
We do conduct extensive secondary research and primary research. Our secondary research sources include Company websites, presentations, annual reports, SEC filings, press releases, industry news, Journals, Articles, publications, white papers, WHO stats, World Bank stats, Region/Country Organizations reports/statistics, etc. Primary sources include C-Level, D-Level executives from manufacturers, product managers, sales & marketing managers, regional/country level sales executives, purchase department heads in hospitals, ambulatory care centers, and other key industry experts. We conduct interviews with primary sources by telephonic conversations, sharing questionnaires, sharing online links.
- Diagnostic Nuclear Medicine
- Therapeutic Nuclear Medicine
- Cardinal Health, Inc
- Bracco Imaging S.p.A
- GE Healthcare
- Eczacibasi-Monrol Nuclear Products
- Nordion, Inc
- Bayer Healthcare
- Lantheus Medical Imaging, Inc.
- Advanced Accelerator Applications S.A
1.1 Market Definition and Scope
1.2 Base Currency, Base Year and Forecast Periods
1.3 Key Research Objectives
1.4 Research Highlights
2. General Study Assumptions
3. Research Methodology
3.2 Secondary Research
3.3 Primary Research
3.4 Analysis Design
3.5 Study Timeline
4. Market Dynamics
4.4 Market Trends
5. Supply Chain Analysis
6. Company Strategy Analysis
6.1 Merger and Acquisition Analysis
6.2 Agreements, Collaborations and Joint Ventures
6.3 Regional Presence
6.4 New Product Launches
7. Market Outlook
7.1 Technological Advancement
7.2 Pricing Analysis
7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)
8. Market Segmentation
8.2 United States Nuclear Medicine Market , By Type , forecast year 2021-2026
8.2.1 Diagnostic Nuclear Medicine
8.2.2 Flight Simulators
8.2.3 Therapeutic Nuclear Medicine
8.2.4 Market Size Estimations & Forecasts (2021-2026)
8.2.5 Y-o-Y Growth Analysis
8.2.6 Market Investment Opportunities Analysis
8.3 United States Nuclear Medicine Market, By Application, forecast year 2021-2026
8.3.5 Market Size Estimations & Forecasts (2021-2026)
8.3.6 Y-o-Y Growth Analysis
8.3.7 Market Investment Opportunities Analysis
9. Market Regional and Country Analysis, Forecast 2021-2026
9.2 Regional Trends
9.3 Impact Analysis
9.4 Key Findings
9.5 United States Nuclear Medicine Market , by country, 2021-2026
9.5.1 By Type
9.5.2 By Application
10. Competitive Landscape Analysis
10.1 Market Player
10.1.1 Company Revenue
10.1.2 Business unit
10.1.3 Product Mapping
10.1.4 Geographical Locations
10.2 Company Share Analysis
11. Strategic Analysis
11.1 PESTLE analysis
11.2 Porter’s Five analysis
11.2.1 Bargaining Power of Suppliers
11.2.2 Bargaining Power of Consumers
11.2.3 Threat of New Entrants
11.2.4 Threat of Substitute Products and Services
11.2.5 Competitive Rivalry within the Industry
12. Company Profiles
12.1 Cardinal Health, Inc
12.1.2 Product Portfolio
12.1.3 Financial Details
12.1.4 SWOT Analysis
12.1.5 Market Strategies
12.2 Bracco Imaging S.p.A
12.3 GE Healthcare
12.4 Eczacibasi-Monrol Nuclear Products
12.5 Nordion, Inc
12.6 Bayer Healthcare
12.7 Lantheus Medical Imaging
12.8 Advanced Accelerator Applications S.A
13. Market Guidance